Average Co-Inventor Count = 4.79
ph-index = 27
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Xencor, Inc. (84 from 216 patents)
2. Genentech, Inc. (6 from 3,211 patents)
3. Eli Lilly and Company (4 from 4,428 patents)
4. Chugai Seiyaku Kabushiki Kaisha (2 from 945 patents)
5. Adimab, LLC (1 from 48 patents)
6. F. Hoffmann-la Roche Ag (166 patents)
94 patents:
1. 12215165 - Fc variants with altered binding to FcRn
2. 12059452 - Fusion proteins
3. 11932685 - Fc variants with altered binding to FcRn
4. 11820830 - Optimized Fc variants
5. 11618788 - Optimized antibodies that target CD19
6. 11542308 - FLT3 ligand fusion proteins and methods of use
7. 11447552 - Methods and compositions for inhibiting CD32B expressing cells
8. 11434295 - Methods and compositions for inhibiting CD32B expressing cells
9. 11401348 - Heterodimeric Fc variants
10. 11352412 - CTLA4-IG immunoadhesins
11. 11254727 - CTLA4-Ig immunoadhesins
12. 11253574 - Fusion proteins and methods of use
13. 11198739 - Fc variants with altered binding to FcRn
14. 11098129 - Anti-transferrin receptor antibodies and methods of use
15. 11008403 - Anti-transferrin receptor / anti-BACE1 multispecific antibodies and methods of use